Table 1.

Characteristics of study patients.

	Number	Mean ± SD	Median
Age, years	444	69.8 ± 10.2	70.0
Body height, cm	444	151.9 ± 6.3	152.0
Body weight, kg	444	51.5 ± 9.1	50.2
BMI, kg/m2	444	22.3 ± 3.5	21.8
Trunk circumference, cm	430	84.2 ± 9.4	84.0
Trunk fat, %	439	27.4 ± 10.6	27.6
Hip fat, %	436	23.7 ± 5.0	23.5
Lumbar BMD, g/cm2	444	0.96 ± 0.19	0.93
T-score for lumbar BMD, SD	444	− 1.59 ± 1.30	− 1.81
Hip BMD, g/cm2	438	0.77 ± 0.12	0.77
T-score for hip BMD, SD	438	− 1.33 ± 1.03	− 1.40
Albumin, g/dL	411	4.2 ± 0.3	4.3
BUN, mg/dL	424	16.1 ± 4.2	16.0
Creatinine, mg/dL	444	0.64 ± 0.13	0.60
Uric acid, mg/dL	439	4.5 ± 1.2	4.5
eGFR, mL/min/1.73m2	444	72.8 ± 16.1	72.6
Total cholesterol, mg/dL	443	209.2 ± 35.2	208.0
Triglyceridesa, mg/dL	443	146.3 ± 92.9	121.5
HbA1c, %	443	5.6 ± 0.8	5.4
Homocysteine, nmol/mL	433	8.9 ± 3.0	8.3
Folic acid, ng/mL	429	9.7 ± 4.2	8.9
NTx, nmolBCE/mmolCre	439	51.3 ± 27.2	45.7
Osteocalcin, ng/mL	394	7.1 ± 2.8	6.6
Sclerostin, pmol/L	397	36.0 ± 14.8	33.0
FGF23, pg/mL	391	40.7 ± 14.6	38.9
Leptin, ng/mL	396	10.3 ± 8.9	8.0
Adiponectin, µg/mL	390	15.3 ± 8.2	13.2
Calcium, mg/dL	441	9.4 ± 0.5	9.4
Inorganic phosphorus, mg/dL	441	3.5 ± 0.5	3.5
25-OH vitamin D, ng/mL	412	20.6 ± 6.1	20.0
PTH, pg/mL	424	42.7 ± 16.7	40.0
PEN, pmol/mgCre	444	33.5 ± 11.2	32.2
CML, µg/mL	442	1.6 ± 0.7	1.6
Diabetes mellitus, yes	89 (20.0%)
Dyslipidemia, yes	214 (48.2%)
Hypertension, yes	220 (49.5%)
Prevalent long-bone fracture, yes	33 (7.4%)
Prevalent vertebral fracture, yes	106 (23.9%)

SD standard deviation, BMI body mass index, BMD bone mineral density, BUN blood urea nitrogen, eGFR estimated glomerular filtration rate, HbA1c hemoglobin A_1c, NTx cross-linked N-telopeptide of type I collagen, FGF23 fibroblast growth factor 23, PTH parathyroid hormone, PEN pentosidine, CML carboxymethyl-lysine.

^aTriglycerides were measured with the patient in a postprandial state.